Purchase Order 75D30121P12319

Award Date 8/10/21
Potential Completion Date 9/30/21
Potential Value $90K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Collins, CO 80521, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $249,000 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Diasorin Inc., a foreign-owned for-profit company, for its "SCIENCE TEAM" requirement. The contract has an ultimate completion date of September 28, 2024. Diasorin Inc. is a manufacturer of fully automated diagnostic testing equipment, assays, reagents, and related services for the medical industry. It has a proven track record as a federal contractor,...
This is a $74,400 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract is for "SERVICE FOR LIAISON XL" and does not have a set-aside designation. Diasorin Inc. is a subsidiary of the Italian-based Diasorin S.P.A. The company specializes in providing advanced diagnostic testing equipment, assays, reagents, and related services to federal healthcare agencies....
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to Diasorin Inc., a foreign-owned, for-profit manufacturer of diagnostic testing equipment, assays, and reagents. The contract, valued at $794,162.20, is for patient care testing services. Diasorin Inc. is a subsidiary of the parent company Diasorin S.P.A. and has a proven track record as a federal contractor, providing chemiluminescence immunoassay analyzers,...
This is a $120,500.00 firm fixed price purchase order awarded by the Department of the Air Force Materiel Command Lifecycle Management Center to Diasorin Inc., a foreign-owned for-profit organization that provides medical diagnostic products and services. The contract is for the delivery of Diasorin reagents and does not have a set-aside designation. Diasorin has supported various federal healthcare programs, including supplying reagents for Liaison XL immunoassay analyzers to the Department...
This federal contract award to Diasorin Inc., a foreign-owned for-profit company, is for REAGENTS AND ANALYZERS in support of the Defense Health Agency (DHA). The $1,307,613.20 firm fixed price purchase order has a period of performance through September 30, 2029. Diasorin Inc. is a subsidiary of the Italian parent company Diasorin S.P.A. and has a long history of providing diagnostic testing equipment, assays, reagents, and related services to federal agencies like the Department of Veterans...
This federal contract award to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, is for the provision of reagents, equipment, and related services under a Blanket Purchase Agreement (BPA) call. The $100,000 fixed-price contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense (DoD), to support medical operations across DoD and Department of Veterans Affairs (VA) healthcare facilities. Diasorin has a strong track record as a federal...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health Clinical Center to Diasorin Inc., a foreign-owned for-profit medical diagnostics company. The contract, valued at $198,689.88, is for a rental reagent agreement for the Diasorin XL diagnostic instrument. No set-aside designation was used. Diasorin has a history of providing diagnostic testing products and services to federal agencies such as the Department of...
This federal contract award to Diasorin Inc. is for in vitro diagnostic substances, reagents, test kits, and sets. The $599,579 firm fixed price contract was issued by the Air Force Materiel Command, a defense agency, and has a completion date of September 30, 2016. The award is not associated with a set-aside program. Diasorin Inc. is a foreign-owned, for-profit company that specializes in automated diagnostic testing equipment, assays, reagents, and related services for the medical industry....
This federal contract award, valued at $90,000.00, was issued by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit company specializing in diagnostic testing equipment and reagents. The contract is for the procurement of LIAISON XL testing equipment, which is used for a variety of infectious disease testing including COVID-19 and tuberculosis. Diasorin Inc. has a proven track record as a federal...
This federal contract award for $350,000 was issued by the Defense Health Agency (DHA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract is for the provision of reagents and closely associated functions, with an ultimate completion date of September 30, 2017. This award is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. Diasorin Inc. is a subsidiary of the Italian-based Diasorin S.P.A. and has a significant presence in the U.S....

This federal contract award to Diasorin Inc., a foreign-owned for-profit company, is for the procurement of DIASORIN IMMUNOCHEMISTRY ANALYZERS by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. The $89,993.50 firm fixed-price purchase order has a completion date of September 30, 2021.

Diasorin Inc. is an experienced federal contractor, providing diagnostic testing equipment, assays, reagents, and related services to agencies like the Department of Veterans Affairs (VA), Department of Defense (DoD), and Department of Health and Human Services (HHS). This award is not associated with a set-aside program. Diasorin holds several indefinite delivery contracts (IDCs) and a General Services Administration (GSA) Multiple Award Schedule to efficiently deliver its state-of-the-art diagnostic solutions across federal healthcare networks.

Generated 4/1/25, 6:44 PM